title: Relapse of intestinal and hepatic amebiasis after treatment.
authors.affiliation: Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University Medical Center, 300 Pasteur Drive, Alway Building, M211, Stanford, CA 94305-5187, USA. ehwang@stanford.edu
authors.forename: Elizabeth W
authors.initials: EW
authors.lastname: Hwang
authors.forename: Lawrence
authors.initials: L
authors.lastname: Cheung
authors.forename: Amirkaveh
authors.initials: A
authors.lastname: Mojtahed
authors.forename: Christine A
authors.initials: CA
authors.lastname: Cartwright
mesh_terms: D000563:Amebicides / Q000627:therapeutic use*; D000930:Antidiarrheals / Q000627:therapeutic use; D003113:Colonoscopy; D004359:Drug Therapy, Combination; D004404:Dysentery, Amebic / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D004103:Iodoquinol / Q000627:therapeutic use; D007964:Leukocytosis / Q000188:drug therapy; D008101:Liver Abscess, Amebic / Q000175:diagnosis / Q000188:drug therapy*; D008139:Loperamide / Q000627:therapeutic use; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use; D008875:Middle Aged; D010303:Paromomycin / Q000627:therapeutic use; D012008:Recurrence; D014011:Tinidazole / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000563:Amebicides; D000930:Antidiarrheals; D014011:Tinidazole; D008795:Metronidazole; D010303:Paromomycin; D004103:Iodoquinol; D008139:Loperamide